The 8th Joint ACTRIMS-ECTRIMS Meeting - MSVirtual2020 - To be Held September 11-13 With A Special Encore Session Featuring COVID-19 & MS and Late Breakers on September 26th

News provided by

Americas Committee for Treatment and Research in Multiple Sclerosis

Aug 31, 2020, 07:00 ET

~Program to Focus on Advances and Breakthroughs in MS Research, Diagnostics and Technology~

~Special Press Events Planned to Give Media Access to Key Leaders & Late Breaker Investigators~

MIDDLETON, Wis., Aug. 31, 2020 /PRNewswire/ -- The 8th Joint ACTRIMS-ECTRIMS Meeting, the largest international conference focused on Multiple Sclerosis (MS) research, will be held in a virtual format from September 11-13, 2020, with a special encore session featuring Late-Breaking News and a COVID-19 Session on September 26.

At this virtual conference – MSVirtual2020 – world class scientists, neurologists, clinicians and researchers from around the world will be presenting the latest research, clinical trial outcomes and technology and diagnostic advances in multiple sclerosis (MS).

Media registration, which is open to editors, reporters, producers, and active freelance writers and bloggers, will allow access to the full program including plenary sessions, invited speakers and platform presentations. Press Registration can be completed online here, or to expedite press registration, you can send a request directly to the Press Managers. They can be reached at: [email protected] and [email protected]. They are also available to arrange interviews with participating leaders, presenters and experts that you may wish to connect with.

The MSVirtual2020 program at a glance can be found here. Key topics will cover:

  • Cutting-edge research into the cause of MS, ranging from epigenetics and genetic factors, to defining the intricate immunological and pathological pathways that inform drug discovery and therapeutic interventions.
  • Radiological advances and machine learning approaches and how these techniques can help us better understand MS.
  • Biomarkers of disease activity and response to therapy, which is critical for the future of personalized medicine in MS.
  • The outcomes of recent clinical trials of new agents and interventions, innovations in symptomatic and rehabilitative therapy, and current research on MS and COVID-19.

Keynote speakers will include:

  • Opening Remarks: September 11 @9:00 a.m. ET
  • Closing Remarks: September 13th @ 2:30 p.m. ET 

MSVirtual2020 will be hosting a Newsroom on Newswise that will house various media materials including press releases, videos, infographics, bios & photos of leaders and speakers, and other assets.  Newswise will also host a few Zoom press events for media only that will allow registered journalists to access and ask live questions to ACTRIMS-ECTRIMS leaders and late breaking investigators. The link to the MSVirtual2020 Newsroom is: here, or at the following link: https://www.newswise.com/home/actrims. The conference hashtag is: #MSVirtual2020.

MSVirtual2020 Press Events:

  • Opening Press Conference with ACTRIMS and ECTRIMS Leaders with live Q&A (Media only)
    • Friday, September 11th @ 8:00 a.m. ET
  • Virtual Coffee Break with ACTRIMS President and Q&A (Media Only)
    • Sunday, September 13th @ 7:30 a.m. ET
    • An opportunity to ask the President questions regarding key presentations, major research, clinical, technology and rehabilitation advances, and what's next for MS 
  • Early Availability of Embargoed Late Breaker Abstracts for Media Only (Upon Request)
    • Thursday Morning, September 24th @ 9:00 a.m. ET
  • Late-Breaker Press Event – Live Q&A with Late Breaker and COVID-19 Investigators  (Media only)
    • Friday, September 25th @ 9:00 a.m.ET
  • Encore Event:  Late Breaker Presentations (Open to all attendees and media)
    • Saturday, September 26th from 9-10:30 a.m. ET 
  • Encore Event:  Covid-19 and MS Special Session (For all attendees and media)
    • Saturday, September 26th from 10:45 a.m.-12:15 p.m. ET 

SOURCE Americas Committee for Treatment and Research in Multiple Sclerosis

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED